Although the underlying mechanism by which AS-1 decreased blood pressures in Ang II-treated mice was not explored, our data provide an idea that AS-1 might have powerful potentials in the treatment of cardiac hypertrophy induced by hypertension. Here, PTGDR is linked to cardiac hypertrophy.